Abbonarsi

Intralacrimal migration of Masterka® stents - 09/04/18

Migrations intralacrymales des sondes Masterka®

Doi : 10.1016/j.jfo.2017.11.009 
B. Fayet a, , b , E. Racy c, W.R. Katowitz d, J.A. Katowitz d, J.-M. Ruban e, D. Brémond-Gignac b, f
a Ophthalmology Department, hôpitaux universitaires Paris Centre, hôpital Cochin, 27, rue du Faubourg-Saint-Jacques, 75014 Paris, France 
b Ophthalmology Department, University Hospital Necker–Enfants malades, AP–HP, Paris V René Descartes University, 149, rue de Sèvres, 75015 Paris, France 
c ENT Department, clinique Saint-Jean-de-Dieu, 2, rue Rousselet, 75007 Paris, France 
d Division of Ophthalmology, The Children's Hospital of Philadelphia and the University of Pennsylvania, 19104 Pennsylvania, USA 
e Ophthalmology Department, Edouard Herriot Hospital, place d’Arsonval, 69003 Lyon, France 
f CNRS Research Unit FR3636, Paris V University, 75005 Paris, France 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Summary

Background

Tearing and conjunctivitis in children are commonly due to lacrimal drainage system obstruction. Congenital nasolacrimal obstruction is a common pathology treated by probing with or without silicone stent insertion, depending upon the age of the child. The silicone stent is self-retaining and placed for at least one month. Masterka® is a recent version of Monoka®, which may lead to the same surgical complications, such as intralacrimal migration.

Subjects and methods

The medical records of two patients surgically treated with the Masterka® probe for nasolacrimal duct obstruction, who developed intralacrimal migration of the stent, were retrospectively reviewed and analyzed. A 41-month-old child and an 18-month-old child presented with disappearance of the silicone tube after 7 days and 2 years respectively. In the first case, the tube migrated completely within the lacrimal system and became externalized through the nose at 2 years, while in the second case, the Masterka® was retrieved through a canalicular approach. In both cases, infants had no further tearing.

Discussion

The frequency self-retaining stent disappearance is estimated at 15%. Among these cases, intralacrimal migration is only reported in 0.5% of cases. To prevent intralacrimal migration, the surgical technique must follow a certain number of rules. Management, based on residual epiphora, is discussed.

Conclusion

Prevention of intralacrimal migration of self-retaining stents involves a rigorous analysis of the relationship between the meatus and the fixation head at the time of placement. After lacrimal intubation, scheduled monitoring is necessary to screen for stent disappearance. Management is based on clinical findings, anterior rhinoscopy and even exploratory canaliculotomy.

Il testo completo di questo articolo è disponibile in PDF.

Résumé

Introduction

L’obstruction congénitale des voies lacrymales de l’enfant est une pathologie fréquente, traitée classiquement par sondage ou intubation en fonction de l’âge de l’enfant. Les sondes à fixation méatique autostable doivent rester en place un mois environ. La Masterka® est une variété récente de Monoka®. Elle donne lieu aux mêmes complications comme la migration intralacrymale.

Matériel et méthodes

Deux cas cliniques d’enfants présentant une imperforation lacrymonasale rebelle traitée par Masterka® sont rapportés et analyses rétrospectivement. Chez ces deux enfants, âgés respectivement de 41 et 18 mois, la disparition de leur sonde a été constatée après respectivement 7jours et 2 ans d’intubation. Dans le premier cas la sonde a complètement migré à l’intérieur de la voie lacrymale jusqu’à son extériorisation nasale après deux années, tandis que dans le deuxième cas, la Masterka® a été retirée après un abord canaliculaire.

Discussion

La fréquence de disparition des sondes à fixation méatique autostable est d’environ 15 %. Parmi elles, les migrations intralacrymales ne représentent que seulement 0.5 % des cas. Pour prévenir la migration intralacrymale, la technique chirurgicale doit suivre un certain nombre de règles. La conduite à tenir, fonction de l’épiphora résiduel, est discutée.

Conclusion

La prévention des migrations intralacrymales des sondes autostables passe par une analyse rigoureuse des rapports méat–tête de fixation au moment de la pose. Après intubation lacrymale, une surveillance planifée est nécessaire pour dépister une disparition de sonde. La conduite à tenir est basée sur : clinique, rhinoscopie antérieure, voire canaliculotome exploratrice.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Lacrimal duct, Epiphora, Nasolacrimal duct obstruction, Congenital nasolacrimal obstruction, Monocanalicular, Intubation, Pushed intubation, Masterka®

Mots clés : Voies lacrymales, Larmoiement, Imperforation lacrymonasale, Obstruction lacrymo-nasale congénitale, Mono-canaliculaire, Intubation, Intubation poussée, Masterka®


Mappa


© 2018  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 41 - N° 3

P. 206-211 - Marzo 2018 Ritorno al numero
Articolo precedente Articolo precedente
  • Évaluation de la qualité de vie des patients équipés en verres scléraux à l’aide d’une version marocaine du NEI-VFQ 25
  • M. Baali, S. Belghmaidi, H. Ahammou, S. Belgadi, I. Hajji, A. Moutaouakil
| Articolo seguente Articolo seguente
  • Complications oculoplastiques de l’exérèse des méningiomes à extension orbitaire
  • N. Stoll, P. Paquis, M. Lonjon, S. Baillif, J. Lagier

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.